Solid Biosciences Inc. is a Strong Buy driven by positive FDA alignment on phase 3 IMPACT DUCHENNE trial for SGT-003. Read more on SLDB stock here.
With a clutch of key data and planned regulatory applications this year from Avidity Biosciences, REGENXBIO and Capricor ...
The Register on MSN
How the GNU C compiler became the Clippy of cryptography
Security devs forced to hide Boolean logic from overeager optimizer FOSDEM 2026 The creators of security software have encountered an unlikely foe in their attempts to protect us: modern compilers.… ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results